CGEM
#2219
Cullinan Therapeutics, Inc. - Common Stock
22.6 0 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.09%
Monthly Change
+28.05%
6 month change
+48.49%
Year Change
+195.42%
Previous Close
22.8 5
Open
22.6 0
Low
22.6 0
High
22.6 0
Volume
62
Financials
- Market Capitalization 1.45 B
- Employee 109
- Founded 2016
- CEO N/A
- Website www.cullinantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00HW2DGQ4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2199 |  NVAX Novavax, Inc. - Common Stock | 9.05 USD | -1.74% | +7.23% | +24.14% | +19.71% | 1.49 B USD | ||
| 2211 |  REPL Replimune Group, Inc. - Common Stock | 15.60 USD | -1.76% | +12.55% | +197.14% | +191.04% | 1.47 B USD | ||
| 2233 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 13.74 USD | -1.22% | -1.86% | +15.56% | +1.70% | 1.42 B USD | ||
| 2234 |  ANRO Alto Neuroscience, Inc. Common Stock | 36.22 USD | -0.90% | +4.83% | +32.19% | +845.69% | 1.42 B USD |
Frequently asked questions about Cullinan Therapeutics, Inc. Common Stock
What is the Cullinan Therapeutics, Inc. Common Stock stock price today?
The current price of Cullinan Therapeutics, Inc. Common Stock (CGEM) is 22.6. Over the past 24 hours, the stock has changed by -1.09%. Follow the CGEM chart for real-time price dynamics.
What is the stock ticker of Cullinan Therapeutics, Inc. Common Stock?
Cullinan Therapeutics, Inc. Common Stock trades under the ticker CGEM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cullinan Therapeutics, Inc. Common Stock stock going up?
CGEM has changed by +4.05% over the last week, +28.05% over the last month, and +195.42% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cullinan Therapeutics, Inc. Common Stock?
Cullinan Therapeutics, Inc. Common Stock currently has a market capitalization of 1.45 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What was Cullinan Therapeutics, Inc. Common Stock revenue for the last quarter?
Cullinan Therapeutics, Inc. Common Stock reported quarterly revenue of 3.55 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Cullinan Therapeutics, Inc. Common Stock net income for the last quarter?
Cullinan Therapeutics, Inc. Common Stock reported net income of -53.7 M for the last quarter. The previous quarter showed -49.66 M, which means net income changed by -8.14%.
How many employees does Cullinan Therapeutics, Inc. Common Stock have?
As of the latest available data, Cullinan Therapeutics, Inc. Common Stock has 109 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cullinan Therapeutics, Inc. Common Stock EBITDA?
Cullinan Therapeutics, Inc. Common Stock EBITDA is -53.63 M, and its EBITDA margin is -1 510.56%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cullinan Therapeutics, Inc. Common Stock stock?
You can buy Cullinan Therapeutics, Inc. Common Stock (CGEM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cullinan Therapeutics, Inc. Common Stock stock?
Investing in Cullinan Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CGEM chart and related analysis on metatrader.com as part of your research.